DEBIO SPHERE Trademark

Trademark Overview


On Monday, January 16, 2023, a trademark application was filed for DEBIO SPHERE with the United States Patent and Trademark Office. The USPTO has given the DEBIO SPHERE trademark a serial number of 79368652. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, October 30, 2024. This trademark is owned by Debiopharm International SA. The DEBIO SPHERE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical products and substances, namely, poly-lactic-co-glycolic acid (PLGA) formulations

Implantable devices, namely, a kit comprising a prefilled syringe or vial that contains a pharmaceutical composition for use for the subcutaneous release of medicated substances

General Information


Serial Number79368652
Word MarkDEBIO SPHERE
Filing DateMonday, January 16, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, October 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical products and substances, namely, poly-lactic-co-glycolic acid (PLGA) formulations
Goods and ServicesImplantable devices, namely, a kit comprising a prefilled syringe or vial that contains a pharmaceutical composition for use for the subcutaneous release of medicated substances

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 5, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, May 5, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDebiopharm International SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, May 4, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 9, 2023APPLICATION FILING RECEIPT MAILED
Thursday, October 12, 2023ASSIGNED TO EXAMINER
Tuesday, October 17, 2023NON-FINAL ACTION WRITTEN
Wednesday, October 18, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 25, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 25, 2023REFUSAL PROCESSED BY MPU
Monday, November 13, 2023REFUSAL PROCESSED BY IB
Thursday, May 16, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 16, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, May 16, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, July 16, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, July 16, 2024PETITION TO REVIVE-GRANTED
Tuesday, July 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 2, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, October 19, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, October 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 2, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 30, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, October 23, 2024ASSIGNED TO LIE
Wednesday, October 30, 2024FINAL REFUSAL E-MAILED
Wednesday, October 30, 2024FINAL REFUSAL WRITTEN